Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Adrenal Cortex Carcinoma”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Looking for participantsNCT06900595
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Who this might be right for
Locally Advanced Adrenal Cortical CarcinomaMetastatic Adrenal Cortical CarcinomaRecurrent Adrenal Cortical Carcinoma+3 more
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00304070
What this trial is testing

Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor

Who this might be right for
Stage I Adrenal Cortical Carcinoma AJCC v7Stage II Adrenal Cortical Carcinoma AJCC v7Stage III Adrenal Cortical Carcinoma AJCC v7+1 more
Children's Oncology Group 78
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Testing effectiveness (Phase 2)Ended earlyNCT00002921
What this trial is testing

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

Who this might be right for
Adrenocortical Carcinoma
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Early research (Phase 1)Looking for participantsNCT07189403
What this trial is testing

DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Advanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 40
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT00924989
What this trial is testing

OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Ended earlyNCT00003453
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

Who this might be right for
Stage IV Adrenocortical Carcinoma
Burzynski Research Institute 6
Very early researchStudy completedNCT00436410
What this trial is testing

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Who this might be right for
Adrenocortical CarcinomaBreast CancerColorectal Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)UnknownNCT03612232
What this trial is testing

Cabozantinib in Advanced Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Wuerzburg University Hospital 37
Large-scale testing (Phase 3)Study completedNCT00094497
What this trial is testing

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Who this might be right for
Carcinoma, Adrenal Cortical
Collaborative Group for Adrenocortical Carcinoma Treatment 304
Testing effectiveness (Phase 2)Looking for participantsNCT06066333
What this trial is testing

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical CarcinomaACCMetastatic Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00848016
What this trial is testing

Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Study completedNCT03370718
What this trial is testing

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Who this might be right for
Metastatic Carcinoma in the Adrenal CortexStage III Adrenal Cortex Carcinoma AJCC v8Stage IV Adrenal Cortex Carcinoma AJCC v8+1 more
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743138
What this trial is testing

STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
M.D. Anderson Cancer Center 20
Next Page